Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

Cisplatin-containing chemotherapy represents the first-line treatment for patients with locally advanced or metastatic muscle-invasive bladder cancer. Recently, novel therapies have become available for cisplatin-ineligible or -resistant patients. Therefore, prediction of cisplatin response is requi...

Full description

Bibliographic Details
Main Authors:	Csilla Olah, Stephan Tschirdewahn, Michèle J. Hoffmann, Ulrich Krafft, Boris Hadaschik, Peter Nyirady, Attila Szendröi, Orsolya Módos, Anita Csizmarik, Ilona Kovalszky, Henning Reis, Tibor Szarvas
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Diagnostics
Subjects:	muscle-invasive bladder cancer SDC1 chemotherapy cisplatin metastasis Matrix Metalloproteinase—7 (MMP-7)
Online Access:	https://www.mdpi.com/2075-4418/10/11/864

Similar Items

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
by: Tibor Szarvas, et al.
Published: (2020-12-01)

Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
by: Petra Terézia Kovács, et al.
Published: (2022-03-01)

Bi-directional immuno-modulation by Matrix Metalloproteinase-7 (MMP-7) and A Disintegrin And Metalloproteinase-17 (ADAM-17) as transplantation rejection-tolerance spectrum
by: Robert Chen
Published: (2016-05-01)

Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis
by: András Kubik, et al.
Published: (2023-04-01)

The Expression Level and Clinical Significance of MMP-7 Protein  in Peripheral Blood in the Patients with Lung Cancer
by: Xiaoliang SUN, et al.
Published: (2012-12-01)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
by: Barbara Maria Piskór, et al.
Published: (2021-04-01)

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy
by: Ulrich Krafft, et al.
Published: (2021-05-01)

Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide
by: Bohee Jang, et al.
Published: (2022-05-01)

Colocalization with MMP-7 in the Distal Colon is Crucial for Syndecan-2 Shedding in Dextran Sulfate Sodium-Induced Colitis Mice
by: Hong H, et al.
Published: (2021-09-01)

Association of the MMP7 –181A>G promoter polymorphism with early onset of chronic obstructive pulmonary disease
by: Tacheva T, et al.
Published: (2017-12-01)

Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature
by: Mark Nomden, et al.
Published: (2020-12-01)

A practical example of an integrated interoperable neuromonitoring system based on IEEE 11073 SDC and HL7
by: Weßbecher Lea, et al.
Published: (2023-09-01)

Unique Sensitivity of Uterine Tissue and the Immune System for Endometriotic Lesion Formation
by: Stephanie A. Morris, et al.
Published: (2021-12-01)

Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
by: Etienne J. Slapak, et al.
Published: (2020-04-01)

Matrix metalloproteinase 2 knockdown suppresses the proliferation of HepG2 and Huh7 cells and enhances the cisplatin effect
by: Liu Jiangwei, et al.
Published: (2019-05-01)

Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data
by: Tiemo S. Gerber, et al.
Published: (2021-06-01)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
by: Csilla Olah, et al.
Published: (2023-03-01)

<i>Bacteroides fragilis</i> Enterotoxin Upregulates Matrix Metalloproteinase-7 Expression through MAPK and AP-1 Activation in Intestinal Epithelial Cells, Leading to Syndecan-2 Release
by: Jong Ik Jeon, et al.
Published: (2021-10-01)

Effect of Ulinastatin on Syndecan-2-Mediated Vascular Damage in IDH2-Deficient Endothelial Cells
by: Su-jeong Choi, et al.
Published: (2022-01-01)

Syndecan-2 modulates the YAP pathway in epithelial-to-mesenchymal transition-related migration, invasion, and drug resistance in colorectal cancer
by: Yang Yang, et al.
Published: (2023-10-01)

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
by: Yufei Zhu, et al.
Published: (2022-10-01)

Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells
by: Silvia Ancona, et al.
Published: (2021-11-01)

Expression of Matrix Metalloproteinases 7 and 9, Desmin, Alpha-Smooth Muscle Actin and Caldesmon, in Odontogenic Keratocyst Associated with NBCCS, Recurrent and Sporadic Keratocysts
by: Carla Loreto, et al.
Published: (2022-06-01)

MMP-7 and MMP-9 are overexpressed in the synovial tissue from severe temporomandibular joint dysfunction
by: Carla Loreto, et al.
Published: (2020-04-01)

Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage
by: Chao Song, et al.
Published: (2022-04-01)

MMP‐7, ‐8, ‐9, E‐cadherin, and beta‐catenin expression in 34 ameloblastoma cases
by: Jetta Kelppe, et al.
Published: (2021-02-01)

Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs
by: Raffaella Petruzzelli, et al.
Published: (2019-09-01)

MicroRNA-203 Regulates Growth and Metastasis of Breast Cancer
by: Shan Zhao, et al.
Published: (2015-08-01)

Adult-Onset Acquired Partial Lipodystrophy Accompanied by Rheumatoid Arthritis
by: Yusuke Muto, et al.
Published: (2015-04-01)

Impact of High Serum Levels of MMP-7, MMP-9, TGF-β and PDGF Macrophage Activation Markers on Severity of COVID-19 in Obese-Diabetic Patients
by: Nasr El-Din A, et al.
Published: (2021-09-01)

An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement
by: C. Loreto, et al.
Published: (2013-04-01)

Assessment of soluble syndecan-1 level in adult patients with de novo acute myeloid leukemia and its correlation with hematological parameters and treatment response
by: Riyam Ismael Shaker, et al.
Published: (2023-01-01)

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
by: Liang Ma, et al.
Published: (2022-04-01)

Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells
by: Ashish Kumar-Singh, et al.
Published: (2021-06-01)

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients
by: Axel Muendlein, et al.
Published: (2022-10-01)

LONG-TERM TREATMENT RESULTS OF BONE SARCOMA PATIENTS WITH CONSIDERATION OF SERUM METALLOPROTEINASE LEVELS
by: I. V. Babkina, et al.
Published: (2016-02-01)

The Anti-Inflammatory Effect of Omega-7 Against Cisplatin in Rat Model
by: Shrouq H Mahmood, et al.
Published: (2022-12-01)

Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma
by: Shuo Yuan, et al.
Published: (2020-01-01)

MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells
by: J. Zhang, et al.
Published: (2014-02-01)

Role of Matrix Metalloproteinases in Angiogenesis and Cancer
by: Saray Quintero-Fabián, et al.
Published: (2019-12-01)